Synonyms Recurrent Synovial Sarcoma, Relapsed Synovial Sarcoma, Synovial Sarcoma Recurrent + [3] |
Introduction The reemergence of synovial sarcoma after a period of remission |
Target |
Mechanism EZH2 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date23 Jan 2020 |
Target |
Mechanism NY-ESO-1 modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism mTORC1 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date10 Jan 2020 |
Sponsor / Collaborator |
Start Date25 Feb 2019 |
Sponsor / Collaborator GSK Plc [+1] |
Start Date13 Sep 2018 |
Sponsor / Collaborator |